aap Implantate announced that in 1Q22, first surgeries occurred as part of a human clinical trial to evaluate the company’s antibacterial silver coating technology.
aap initiated the human clinical trial in late 2021 as a step toward the planned CE Mark approval of its coating technology.
In addition, aap reports that its antibacterial silver coating technology is effective against the antibiotic-resistant hospital germ methicillin-resistant Staphylococcus aureus (MRSA), which was responsible for 100,000 deaths worldwide in 2019 alone per published studies.
aap’s silver coating is intended to offer an alternative solution, not based on antibiotics, in the fight against bacterial infections. As a platform technology, the coating has a broad range of applications and can be used not only in traumatology, but also in other areas of orthopedics.
Source: aap Implantate
aap Implantate announced that in 1Q22, first surgeries occurred as part of a human clinical trial to evaluate the company's antibacterial silver coating technology.
aap initiated the human clinical trial in late 2021 as a step toward the planned CE Mark approval of its coating technology.
In addition, aap reports that its antibacterial silver...
aap Implantate announced that in 1Q22, first surgeries occurred as part of a human clinical trial to evaluate the company’s antibacterial silver coating technology.
aap initiated the human clinical trial in late 2021 as a step toward the planned CE Mark approval of its coating technology.
In addition, aap reports that its antibacterial silver coating technology is effective against the antibiotic-resistant hospital germ methicillin-resistant Staphylococcus aureus (MRSA), which was responsible for 100,000 deaths worldwide in 2019 alone per published studies.
aap’s silver coating is intended to offer an alternative solution, not based on antibiotics, in the fight against bacterial infections. As a platform technology, the coating has a broad range of applications and can be used not only in traumatology, but also in other areas of orthopedics.
Source: aap Implantate
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.